Username Password
S&P 500: 1,351.68 Change: +0.14%

COVIDIEN PLC NEW (COV)

Overview
Price 52.10
Price Change Today 0.00 (0.00%)
P&P rating Rating: 3
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $52.10
Daily Range $0.00 - $0.00
52-Week Range $41.35 - $57.65
Volume 0
chart
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its business through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular, SharpSafety and clinical care products; Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products.
Other Resources for COV
zacks.com
Commentary
Zacks Blog: Cardica's Losses Trim in 2Q
February 8, 2012
Zacks Blog: Earnings Scorecard: Covidien
February 7, 2012
Zacks Blog: Covidien's Solitaire Ok'd for Trial
January 31, 2012
Zacks Blog: Covidien EPS Tops, Snips Sales View
January 26, 2012
Zacks Blog: Earnings Preview: Covidien
January 25, 2012
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its business through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular, SharpSafety and clinical care products; Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products.
 
Brokerage Analyst Recommendations
19 Brokerage Firms Covering COV
 
   
Strong Buy
16
Buy
1
Hold
2
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.24
 
COV Ratings:BUY  SELL  HOLD
COV Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

5 Buy
0 Sell
 
Top Buy Analysis
BUY: COV Rating: 3
Company: COVIDIEN LTD
Points: -4.73
Start Price: $34.60
Start Date: 12/13/2008 1:49 AM
tblair
tblair
P&P Score: 4.00
Recs:
oncology

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
PaulShark
1.27 12/29/10 W.O.M. WORLD OF MEDICINE AG 40 years track record in medical devices 0
PaulShark
1.27 12/28/10 Hypertension Diagnostics Inc. 0
rjm77me
99.92 08/06/10 This week we've seen notable insider buying 0
Zacks_Analysts
0.00 02/08/12 Cardica's Losses Trim in 2Q - Analyst Blog 0
Zacks_Analysts
0.00 02/07/12 Earnings Scorecard: Covidien - Analyst Blog 0
Zacks_Analysts
0.00 01/31/12 Covidien's Solitaire Ok'd for Trial - Analyst Blog 0
Zacks_Analysts
0.00 01/26/12 Covidien EPS Tops, Snips Sales View - Analyst Blog 0
Zacks_Analysts
0.00 01/25/12 Earnings Preview: Covidien - Analyst Blog 0
Zacks_Analysts
0.00 01/18/12 Covidien Recalls Duet TRS - Analyst Blog 0
Zacks_Analysts
0.00 01/16/12 Cardica Suspends Enrollment - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6   7   8   9  >>
Commentary
BUY: COVIDIEN LTD (COV) Rating: 3
Start Price: $34.60
Points: -4.73
Created: 12/13/2008
oncology

Comments: 0 | Comment

Recs:
 
BUY: COVIDIEN LTD (COV) Rating: 3
Start Price: $47.59
Points: +2.76
Created: 11/11/2011

Comments: 0 | Comment

vip vip
Recs:
 
BUY: COVIDIEN LTD (COV) Rating: 3
Start Price: $52.50
Points: -6.86
Created: 06/17/2011

Comments: 0 | Comment

Recs:
 
BUY: COVIDIEN LTD (COV) Rating: 3
Start Price: $38.01
Points: -21.52
Created: 11/17/2008

Comments: 0 | Comment

Recs:
 
BUY: COVIDIEN LTD (COV) Rating: 3
Start Price: $42.01
Points: +32.20
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
vip 99.98 BUY One to Three Months 11/11/2011 $47.59 $52.21
(-0.55%)
+9.71% +6.95% +2.76
dmonnie 0.21 BUY One to Three Months 06/17/2011 $52.50 $52.21
(-0.55%)
-0.55% +6.31% -6.86
tblair 4.00 BUY Three Plus Years 12/13/2008 $34.60 $52.21
(-0.55%)
+50.90% +55.62% -4.73 view
LeveneOMurray 0.45 BUY Week or Less 11/17/2008 $38.01 $52.21
(-0.55%)
+37.36% +58.88% -21.52
johnq 58.48 BUY Six Months to a Year 01/01/2008 $42.01 $52.21
(-0.55%)
+24.28% -7.92% +32.20
Sponsored Links